Koyfin Home > Directory > Health Care > Aclaris Therapts > Issuance of Common Stock

Aclaris Therapts Issuance of Common Stock Chart (ACRS)

Aclaris Therapts annual/quarterly Issuance of Common Stock from 2015 to 2020.
  • Aclaris Therapts Issuance of Common Stock for the quarter ending March 03, 2020 was $0m a -427,396.00% decrease of -107m year over year
  • Aclaris Therapts Issuance of Common Stock for the last 12 months ending June 06, 2020 was $0m a -52,330.88% decrease of -107m year over year
  • Aclaris Therapts Annual Issuance of Common Stock for 2019 was $0m a -51,808.70% decrease of -107m from 2018
  • Aclaris Therapts Annual Issuance of Common Stock for 2018 was $107m a 0.88% increase of 1m from 2017
  • Aclaris Therapts Annual Issuance of Common Stock for 2017 was $107m a -17.15% decrease of -18m from 2016
Other Cash Flow Metrics:
  • Aclaris Therapts Cash Flow from Operations for the quarter ending September 09, 2018 was $-30m a 39.01% decrease of -12m year over year
  • Aclaris Therapts Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-19m a 51.56% decrease of -10m year over year
  • Aclaris Therapts Total Revenue for the quarter ending September 09, 2018 was $2m a 38.64% increase of 1m year over year
View Chart On Koyfin

Quarterly ACRS Issuance of Common Stock Data

03/2020$0m
12/2019$0m
06/2019$0m
12/2018$107m
03/2018$0m
12/2017$6m
09/2017$81m
06/2017$19m
03/2017$0m
12/2016$106m

Annual ACRS Issuance of Common Stock Data

2019$0m
2018$107m
2017$107m
2016$125m
2015$63m